1. Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial. Issue 9 (September 2020) Authors: Baize, Nathalie; Monnet, Isabelle; Greillier, Laurent; Geier, Margaux; Lena, Hervé; Janicot, Henri; Vergnenegre, Alain; Crequit, Jacky; Lamy, Regine; Auliac, Jean-Bernard; Letreut, Jacques; Le Caer, Hervé; Gervais, Radj; Dansin, Eric; Madroszyk, Anne; Renault, Patrick-Aldo; Le Garff, Gwenaëlle; F... Journal: Lancet oncology Issue: Volume 21:Issue 9(2020) Page Start: 1224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use of immunotherapy in these patients: the GFPC 03-2017 "EPNEC" study. (July 2020) Authors: Arpin, Dominique; Charpentier, Marie-Christine; Bernardi, Marie; Monnet, Isabelle; Boni, Aurelie; Watkin, Emmanuel; Goubin-Versini, Isabelle; Lamy, Régine; Gérinière, Laurence; Geier, Margaux; Forest, Fabien; Gervais, Radj; Madrosyk, Anne; Guisier, Florian; Serrand, Cécile; Locher, Chrystèle; Dec... Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗